G Medical Innovations Holdings Ltd
Other OTCTotal Valuation
G Medical Innovations Holdings Ltd carries a market capitalization of 25,992.00, placing it among publicly traded companies globally. Its enterprise value stands at 9.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 25,992.00 |
| Enterprise Value | 9.65M |
Financial Position
G Medical Innovations Holdings Ltd maintains a current ratio of 0.26, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.26 |
| Quick Ratio | 0.18 |
| Debt / Equity | -201.97 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Stock Price Statistics
G Medical Innovations Holdings Ltd's stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Balance Sheet
G Medical Innovations Holdings Ltd holds 543,000.00 in cash and equivalents against 6.77M in total debt, resulting in a net debt position of 6.23M. Total book value stands at -8.27M, with working capital of -7.08M providing operational flexibility.
| Cash & Cash Equivalents | 543,000.00 |
| Total Debt | 6.77M |
| Net Debt | 6.23M |
| Equity (Book Value) | -8.27M |
| Book Value Per Share | N/A |
| Working Capital | -7.08M |
Stock Splits
G Medical Innovations Holdings Ltd's most recent stock split took place on November 21, 2022 with a 35:1 split ratio.
| Last Split Date | 11/21/2022 |
| Split Ratio | 35:1 |
Scores
G Medical Innovations Holdings Ltd posts an Altman Z-Score of -18.84, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -18.84 |